Unknown

Dataset Information

Complications, revision fusions, readmissions, and utilization over a 1-year period after bone morphogenetic protein use during primary cervical spine fusions.


ABSTRACT:

Background context

Nationwide estimates examining bone morphogenetic protein (BMP) use with cervical spine fusions have been limited to perioperative outcomes.

Purpose

To determine the 1-year risk of complications, cervical revision fusions, hospital readmissions, and health care services utilization.

Study design

A retrospective cohort study from 2002 to 2009 using a nationwide claims database.

Patient sample

There were 61,937 primary cervical spine fusions of which 1,677 received BMP.

Outcome measures

Complications, revision fusions, 30-day hospital readmission, and health care utilization.

Methods

Data for these analyses come from the Thomson Reuters MarketScan Commercial Claims and Encounters Database 2010. Patients were aged 18 to 64 years, r

SUBMITTER: Goode AP 

PROVIDER: S-EPMC4048648 | biostudies-literature | 2014 Sep

REPOSITORIES: biostudies-literature